Originally posted in Medgadget on JULY 24TH, 2015 RADIANT INSIGHTS, INC.
Global Markets Direct’s, ‘Sleep Apnea – Pipeline Review, H2 2014′, provides an overview of the Sleep Apnea’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Sleep Apnea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for Sleep Apnea and special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Originally posted by Karen Weintraub, Special for USA TODAY 10:28 a.m. EDT November 2, 2013
Sleep apnea affects an estimated 5% to 10% of Americans
and is undiagnosed in most of them. It can also lead to
obesity, diabetes, high blood pressure, strokes and heart
For 30 years, Bob Bleck of Mentor, Ohio, snored nearly every night and napped nearly every day.
Finally, his wife got fed up and made him see a doctor. He was diagnosed with obstructive sleep apnea, a condition in which people stop breathing for short periods, disrupting their sleep, sometimes hundreds of times a night.
Sleep apnea used to be seen as a mere annoyance, but in the past decade or two, it has become clear that it can be life-threatening — both to the person with the condition and others on the road.
The best way to fight sleep apnea is to lose weight, MedPage Today reported.
In a paper published by the American College of Physicians, researchers reviewed studies published between 1966 and 2012 in order to determine the best ways to address the problem of sleep apnea – a condition in which an individual briefly stops breathing during sleep. Sleep apnea can lead to problems ranging from daytime sleepiness to cardiovascular disease, and it is becoming an increasingly large medical issue in the United States due to rising rates of obesity, according to Med Page Today.
Overall, researchers concluded that, “some intensive weight-loss programs may effectively reduce signs and symptoms of (obstructive sleep apnea) in obese patients with or without diabetes.”
However, when patients are not overweight or when weight loss interventions fail to relieve apnea, other methods such as continuous positive airway pressure (CPAP) should be attempted, researchers said.
Unlike obstructive sleep apnea, central sleep apnea can be both difficult to diagnose and potentially more dangerous.
According to sleep medicine experts from Ohio State University Wexner Medical Center, more than one-third of heart failure patients are affected by central sleep apnea, making their cardiovascular condition even worse. These doctors now say they’ve tested an intravenous device to alleviate the condition in heart patients.
After trials, doctors saw a 56 percent reduction in overall apnea events per hour and a more than 80 percent reduction in central sleep apnea events. This device could prove beneficial to many as recent studies have shown prolonged bouts of sleep apnea can lead to a myriad of other health conditions.
“One of the concerning features of central sleep apnea is that these patients don’t fit the usual profile of obstructive sleep apnea,” explained Dr.